Influence of Drug-Carrier Polymers on Alpha-Synucleinopathies: A Neglected Aspect in New Therapies Development

Current therapeutic strategies to treat neurodegenerative diseases, such as alpha-synucleinopathies, aim at enhancing the amount of drug reaching the brain. Methods proposed, such as intranasal administration, should be able to bypass the blood brain barrier (BBB) and even when directly intracerebra...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonda-Turo, C., Herva, M., Chiono, V., Ciardelli, G., Spillantini, M. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852847/
https://www.ncbi.nlm.nih.gov/pubmed/29686999
http://dx.doi.org/10.1155/2018/4518060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852847/
https://www.ncbi.nlm.nih.gov/pubmed/29686999
http://dx.doi.org/10.1155/2018/4518060

Ejemplares similares